Low levels or functional changes in complement regulators like CFH—often due to genetic variants—have been linked to autoimmune and inflammatory diseases such as IgAN, systemic lupus erythematosus, and several kidney disorders [19,20,21]. Here, CFH is linked to systemic lupus erythematosus.